NTRB
Price
$4.51
Change
-$0.18 (-3.84%)
Updated
Dec 18, 04:15 PM (EDT)
NWPHF
Price
$9.36
Change
-$2.64 (-22.00%)
Updated
Sep 9 closing price
Ad is loading...

NTRB vs NWPHF

Header iconNTRB vs NWPHF Comparison
Open Charts NTRB vs NWPHFBanner chart's image
Nutriband
Price$4.51
Change-$0.18 (-3.84%)
Volume$100
CapitalizationN/A
Newron Pharmaceuticals SPA
Price$9.36
Change-$2.64 (-22.00%)
Volume$500
CapitalizationN/A
NTRB vs NWPHF Comparison Chart
Loading...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NWPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRB vs. NWPHF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRB is a Hold and NWPHF is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (NTRB: $4.69 vs. NWPHF: $9.36)
Brand notoriety: NTRB and NWPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTRB: 100% vs. NWPHF: 100%
Market capitalization -- NTRB: $52.09M vs. NWPHF: $176.38M
NTRB [@Biotechnology] is valued at $52.09M. NWPHF’s [@Biotechnology] market capitalization is $176.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRB’s FA Score shows that 0 FA rating(s) are green whileNWPHF’s FA Score has 0 green FA rating(s).

  • NTRB’s FA Score: 0 green, 5 red.
  • NWPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, both NTRB and NWPHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRB’s TA Score shows that 6 TA indicator(s) are bullish while NWPHF’s TA Score has 2 bullish TA indicator(s).

  • NTRB’s TA Score: 6 bullish, 3 bearish.
  • NWPHF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, NTRB is a better buy in the short-term than NWPHF.

Price Growth

NTRB (@Biotechnology) experienced а -0.42% price change this week, while NWPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

NTRB is expected to report earnings on Dec 17, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NWPHF($176M) has a higher market cap than NTRB($52.1M). NTRB YTD gains are higher at: 102.155 vs. NWPHF (79.310).
NTRBNWPHFNTRB / NWPHF
Capitalization52.1M176M30%
EBITDA-6.01MN/A-
Gain YTD102.15579.310129%
P/E RatioN/AN/A-
Revenue2.02MN/A-
Total Cash8.35MN/A-
Total Debt528KN/A-
FUNDAMENTALS RATINGS
NTRB vs NWPHF: Fundamental Ratings
NTRB
NWPHF
OUTLOOK RATING
1..100
1043
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5851
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
25n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRB's Valuation (52) in the null industry is in the same range as NWPHF (71). This means that NTRB’s stock grew similarly to NWPHF’s over the last 12 months.

NWPHF's Profit vs Risk Rating (61) in the null industry is somewhat better than the same rating for NTRB (100). This means that NWPHF’s stock grew somewhat faster than NTRB’s over the last 12 months.

NTRB's SMR Rating (97) in the null industry is in the same range as NWPHF (100). This means that NTRB’s stock grew similarly to NWPHF’s over the last 12 months.

NWPHF's Price Growth Rating (51) in the null industry is in the same range as NTRB (58). This means that NWPHF’s stock grew similarly to NTRB’s over the last 12 months.

NWPHF's P/E Growth Rating (100) in the null industry is in the same range as NTRB (100). This means that NWPHF’s stock grew similarly to NTRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRBNWPHF
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
17%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
16%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NWPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRAI206.552.62
+1.28%
CRA International
DOYU11.780.02
+0.17%
DouYu International Holdings Limited
BL64.46-0.48
-0.74%
BlackLine
TROW117.89-1.39
-1.17%
T Rowe Price Group
LSF8.12-0.19
-2.29%
Laird Superfood

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
+5.39%
VRAX - NTRB
31%
Poorly correlated
+10.39%
NOXOF - NTRB
29%
Poorly correlated
N/A
SYRE - NTRB
27%
Poorly correlated
+3.44%
IBIO - NTRB
25%
Poorly correlated
+2.98%
GLMD - NTRB
25%
Poorly correlated
-7.95%
More

NWPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NWPHF has been loosely correlated with NOXOF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NWPHF jumps, then NOXOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWPHF
1D Price
Change %
NWPHF100%
N/A
NOXOF - NWPHF
54%
Loosely correlated
N/A
MMIRF - NWPHF
30%
Poorly correlated
N/A
ACET - NWPHF
27%
Poorly correlated
-0.75%
IGXT - NWPHF
23%
Poorly correlated
N/A
NTRB - NWPHF
19%
Poorly correlated
+5.39%
More